Int Health. 2012 December 1; 4(4): 253–259. doi:10.1016/j.inhe.2012.07.001
Community Health Impact Coalition members & colleagues from across the world are sharing COVID-19 explainers, internal policies, clinical protocols, & more live
A WHO-UNICEF joint statement encouraging greater health commodity supply chain integration for temperature-sensitive pharmaceuticals where appropriate, 19 November 2020
خطة النقاط الست للاستجابة والتعافي ووضع رؤية جديدة لعالم ما بعد الجائحة لكل طفل
Providing improved water supply to low-income urban communities is a difficult challenge faced by water utilities throughout Africa and Asia.
This guide provides an introduction to available options for serving these communities.
The guide draws on sector experience in general, and more particular...ly on WSUP’s extensive experience of implementing urban WASH programmes in sub-Saharan Africa and elsewhere.
more
Les maladies concernées sont les schistosomiases, les géohelminthiases, la lèpre, la rage, la dengue, la leishmaniose, le mycétome, et les envenimassions par morsure de serpents. Tout comme plusieurs autres pays, la Mauritanie se trouve actuellement à un stade où le trachome n'est plus c...onsidéré comme un grand problème de santé publique, même s'il subsiste des foyers d'endémicité. Toutefois, un programme de surveillance est aujourd’hui en place. Si aucun nouveau cas n’est signalé, la Mauritanie sera certifié exempt de trachome en juillet 2022
more
Rreport of a WHO Consultative Meeting Kolkata India 2012
The document contains preliminary report on all aspects of WHO’s response in the Ebola outbreak. WHO Member States will discuss the report at the sixty-eighth World Health Assembly.
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more
Gac Méd Caracas 2018;126(1):52-78
Responsibilidad Social Institucional (RSI)
A Guidebook for Medical and Professional Schools, Second Edition.
This book represents a significant step to engage health professions schools in addressing global health challenges
The humanitarian crisis in Yemen remains the worst in the world. Nearly four years of conflict and severe economic decline are driving the country to the brink of famine and exacerbating needs in all sectors. An estimated 80 per cent of the population – 24 million people – require some form of h...umanitarian or protection assistance, including 14.3 million who are in acute need. Severity of needs is deepening, with the number of people in acute need a staggering 27 per cent higher than last year. Two-thirds of all districts in the country are already pre-famine, and one-third face a convergence of multiple acute vulnerabilities
more
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...demic laid this inequity bare, it also saw the pharmaceutical industry develop and bring new vaccines and treat- ments to market at unprecedented speed. As the world emerges from the worst
of this crisis, pharmaceutical companies are now at an important juncture, where lessons learned from the pandemic can prove pivotal in finding solutions to bridge long-standing gaps in access to medicine in LMICs.
more
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
Annual report on global preparednessfor health emergencies
The next pandemic is not a question of if, but when—and the world is woefully unprepared, according to the first annual report from the Global Preparedness Monitoring Board. The WHO and the World Bank convened the independent group after ...the 2014-2015 Ebola outbreak in West Africa, Global News reports. Within 36 hours, a contagion like the 1918 flu could sweep the globe and take 50 to 80 million lives while wreaking havoc on the global economy, the report warns. And that’s just one possibility.
What would it take to get prepared? An investment of $1-$2 per person per year could create “acceptable” level of preparedness.
more